Provided by Tiger Trade Technology Pte. Ltd.

Cardinal Health

234.57
-1.4500-0.61%
Post-market: 234.570.00000.00%19:48 EDT
Volume:1.11M
Turnover:260.28M
Market Cap:54.56B
PE:32.44
High:239.43
Open:238.77
Low:232.60
Close:236.02
52wk High:258.30
52wk Low:145.87
Shares:232.58M
Float Shares:232.58M
Volume Ratio:0.82
T/O Rate:0.48%
Dividend:2.05
Dividend Rate:0.87%
EPS(TTM):7.23
EPS(LYR):7.23
ROE:-171.32%
ROA:3.72%
PB:-18.92
PE(LYR):32.44

Loading ...

Cardinal Health, Inc : UBS Raises Target Price to $274 from $260

THOMSON REUTERS
·
Jul 20

Cardinal Health Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 17

Cardinal Health Announces Q2 2026 Cash Distribution of R$ 1.78 Per Unit, Payable July 21

Reuters
·
Jul 17

Is Cardinal Health’s (CAH) Specialty and Chronic-Care Pivot Quietly Rewiring Its Risk–Reward Profile?

Simply Wall St.
·
Jul 16

Cardinal Health Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 15

Cardinal Health is Maintained at Buy by TD Cowen

Dow Jones
·
Jul 10

TD Cowen Adjusts Price Target on Cardinal Health to $275 From $255

MT Newswires Live
·
Jul 09

Cardinal Health to Report Fiscal 2026 Fourth-quarter, Year-end Results, Host Webcast

Reuters
·
Jul 09

Cardinal Health Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Evercore ISI Adjusts Price Target on Cardinal Health to $265 From $240

MT Newswires Live
·
Jul 07

Is Cardinal Health (CAH) Fully Valued After Its Russell Index Removal?

Simply Wall St.
·
Jul 04

Cardinal Health is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 02

BofA Securities Adjusts Cardinal Health Price Target to $260 From $240

MT Newswires Live
·
Jul 02

Bank of America Securities Reaffirms Their Buy Rating on Cardinal Health (CAH)

TIPRANKS
·
Jul 02

Neurocrine Begins Phase 2 Trial of Crinecerfont in Children Under 4 Years With Classic CAH Genetic Condition

MT Newswires Live
·
Jul 02

Cardinal Health Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Cardinal Health Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24

What Neurocrine Biosciences (NBIX)'s New CRENESSITY CAH Data Means For Shareholders

Simply Wall St.
·
Jun 22

Cardinal Health Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19